CAMD Publications

The Coalition Against Major Diseases: Developing Tools
for an Integrated Drug Development Process for Alzheimer's and Parkinson's Diseases

Clinical Pharmacology & Therapeutics, 2009;86(4):365-67
Romero K, de Mars M, Frank D, Anthony M, Neville J, Kirby L, Smith K, Woosley R.

Striving for an Integrated Drug-Development Process for Neurodegeneration: The Coalition Against Major Diseases

Neurodeg Dis Management, 2011;1(5):379–385
Romero K, Corrigan B, Neville J, Kopko S, Cantillon M

Beta Regression Meta-Analysis Using a Combination of Patient-level and Summary-level Data, with Application to Alzheimer's Disease

J PKPD. In press
Rogers JA, Polhamus D, Gillespie WR, Ito K, Romero K, Qiu R, Gastonguay MR, Corrigan B. for the Coalition Against Major Diseases and the Alzheimer’s Disease Neuroimaging Initiative

Applications of a Drug-Disease-Trial Model And Clinical Trial Simulation in Drug Development for Alzheimer's Disease

Alzheimer's and Dementia, submitted
Qiu R, Rogers JA, Polhamus D, Romero K, Ito K, Corrigan B

The Advantages of FTD Drug Development (Part 2 of FTD: the Next Therapeutic Frontier)

Alzheimer's and Dementia, submitted
Boxer A, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao F-B, Burton E, Cho T, Kao A, Leavitt B, Lamb B, Grether M, Knopman D, Cairns N, Mackenzie I, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Jackson G, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian Z, Sutherland M, Abushakra S, Lewcock J, Farese R, Kenet RO, LaFerla F, Perrin S, Whitaker S, Honig L, Boeve B, Grossman M, Miller B, and Cummings J

Proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures

MS Journal , in press.
Ontanada D, LaRocca N, Cotzee T, Rudick R, on behalf of the NMSS MSFC Task Force